Variant report

Variant	nsv8285
Chromosome Location	chr8:8285302-8291207
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr8:8285133-8285725	HepG2	liver:	n/a	n/a
2	ARID3A	chr8:8286275-8287368	HepG2	liver:	n/a	n/a
3	ATF3	chr8:8286690-8287352	A549	lung:	n/a	n/a
4	ATF3	chr8:8286695-8287347	A549	lung:	n/a	n/a
5	BCL3	chr8:8286658-8287363	A549	lung:	n/a	n/a
6	BCL3	chr8:8286570-8287287	A549	lung:	n/a	n/a
7	BHLHE40	chr8:8286354-8287280	HepG2	liver:	n/a	n/a
8	BHLHE40	chr8:8285206-8285429	K562	blood:	n/a	chr8:8285292-8285305 chr8:8285288-8285309
9	BHLHE40	chr8:8284870-8286026	HepG2	liver:	n/a	chr8:8285292-8285305 chr8:8285288-8285309
10	BHLHE40	chr8:8285203-8285486	HepG2	liver:	n/a	chr8:8285292-8285305 chr8:8285288-8285309
11	BHLHE40	chr8:8285152-8285676	HepG2	liver:	n/a	chr8:8285292-8285305 chr8:8285288-8285309
12	CEBPB	chr8:8286874-8287324	HepG2	liver:	n/a	n/a
13	CEBPB	chr8:8286803-8287335	HepG2	liver:	n/a	n/a
14	CEBPB	chr8:8286862-8287314	HepG2	liver:	n/a	n/a
15	CEBPB	chr8:8286630-8287443	A549	lung:	n/a	n/a
16	CEBPB	chr8:8286731-8287340	A549	lung:	n/a	n/a
17	CEBPB	chr8:8288159-8288360	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr8:8286999-8287221	HepG2	liver:	n/a	n/a
19	CEBPB	chr8:8286904-8287289	IMR90	lung:	n/a	n/a
20	CEBPB	chr8:8286926-8287259	A549	lung:	n/a	n/a
21	CEBPB	chr8:8285267-8285739	HepG2	liver:	n/a	n/a
22	CEBPD	chr8:8286992-8287221	HepG2	liver:	n/a	n/a
23	CEBPD	chr8:8286964-8287209	HepG2	liver:	n/a	n/a
24	CHD2	chr8:8286860-8287226	HepG2	liver:	n/a	n/a
25	CREB1	chr8:8286512-8287343	HepG2	liver:	n/a	n/a
26	CTCF	chr8:8290858-8290864	Lung_OC	lung:	n/a	n/a
27	EP300	chr8:8286645-8287222	SK-N-SH	brain:	n/a	n/a
28	EP300	chr8:8286615-8287455	A549	lung:	n/a	n/a
29	EP300	chr8:8285220-8285735	HepG2	liver:	n/a	chr8:8285313-8285327 chr8:8285317-8285326
30	EP300	chr8:8285156-8285840	HepG2	liver:	n/a	chr8:8285313-8285327 chr8:8285203-8285217 chr8:8285195-8285209 chr8:8285201-8285215 chr8:8285317-8285326
31	EP300	chr8:8285066-8285805	HepG2	liver:	n/a	chr8:8285313-8285327 chr8:8285203-8285217 chr8:8285195-8285209 chr8:8285201-8285215 chr8:8285317-8285326
32	EP300	chr8:8286653-8287334	HepG2	liver:	n/a	n/a
33	EP300	chr8:8286602-8287311	HepG2	liver:	n/a	n/a
34	EP300	chr8:8286441-8287496	A549	lung:	n/a	n/a
35	EP300	chr8:8286555-8287423	HepG2	liver:	n/a	n/a
36	ETS1	chr8:8286710-8287193	A549	lung:	n/a	n/a
37	FOS	chr8:8286921-8287213	HUVEC	blood vessel:	n/a	chr8:8287087-8287095 chr8:8287085-8287096 chr8:8287085-8287097
38	FOSL2	chr8:8286662-8287384	HepG2	liver:	n/a	chr8:8287087-8287095 chr8:8287085-8287097
39	FOSL2	chr8:8286580-8287459	A549	lung:	n/a	chr8:8287087-8287095 chr8:8287085-8287097
40	FOSL2	chr8:8286688-8287287	A549	lung:	n/a	chr8:8287087-8287095 chr8:8287085-8287097
41	FOSL2	chr8:8286696-8287342	HepG2	liver:	n/a	chr8:8287087-8287095 chr8:8287085-8287097
42	FOXA1	chr8:8286707-8287460	HepG2	liver:	n/a	chr8:8286946-8286958
43	FOXA1	chr8:8285081-8285827	HepG2	liver:	n/a	n/a
44	FOXA1	chr8:8286606-8287454	HepG2	liver:	n/a	chr8:8286946-8286958
45	FOXA1	chr8:8286748-8287382	HepG2	liver:	n/a	chr8:8286946-8286958
46	FOXA1	chr8:8285079-8285928	HepG2	liver:	n/a	n/a
47	FOXA1	chr8:8285067-8285658	HepG2	liver:	n/a	n/a
48	FOXA1	chr8:8285202-8285606	HepG2	liver:	n/a	n/a
49	FOXA1	chr8:8286603-8287363	HepG2	liver:	n/a	chr8:8286946-8286958
50	FOXA2	chr8:8286822-8287473	A549	lung:	n/a	chr8:8286946-8286958

No.	Distal block	Cell Line	Cell type
1	chr8:8286859..8289510-chr8:8290140..8291896,2	MCF-7	breast:
2	chr8:8281489..8283205-chr8:8283537..8285806,2	MCF-7	breast:
3	chr8:8286859..8289510-chr8:8290140..8291896,2	MCF-7	breast:
4	chr8:8285563..8288242-chr8:8289388..8292203,2	K562	blood:
5	chr8:8239788..8242444-chr8:8287010..8288532,2	MCF-7	breast:
6	chr8:8285563..8288242-chr8:8289388..8292203,2	K562	blood:

Variant related genes	Relation type
ENSG00000253505	TF binding region
ENSG00000253505	chromatin interactions

Extended variants
information (count: 362 )
Associated
traits (count: 137 )

Variant overlapped rSNPs/rCNVs (count:362 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10099571	chr8:8285302-8285303	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs568910512	chr8:8285305-8285306	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs147970547	chr8:8285334-8285335	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs117945843	chr8:8285366-8285367	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs554332667	chr8:8285388-8285389	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs574226627	chr8:8285391-8285392	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs576700351	chr8:8285397-8285398	Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs539820619	chr8:8285410-8285411	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs553399136	chr8:8285425-8285426	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs545663208	chr8:8285440-8285441	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs577112541	chr8:8285441-8285442	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs534412337	chr8:8285444-8285445	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs554599489	chr8:8285457-8285458	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs372965943	chr8:8285475-8285476	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs546140614	chr8:8285498-8285499	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs563200340	chr8:8285505-8285506	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs191872936	chr8:8285510-8285511	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs116744907	chr8:8285550-8285551	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs562150792	chr8:8285636-8285637	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs574332716	chr8:8285645-8285646	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs527817562	chr8:8285654-8285655	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs377325237	chr8:8285668-8285669	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs75243343	chr8:8285686-8285687	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs142250782	chr8:8285815-8285816	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs533364206	chr8:8285817-8285818	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs557244493	chr8:8285838-8285839	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs140683268	chr8:8285874-8285875	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs2945859	chr8:8285876-8285877	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs57404945	chr8:8285877-8285878	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs73184381	chr8:8285878-8285879	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs537627980	chr8:8285889-8285890	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs201948000	chr8:8285892-8285893	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs147051194	chr8:8285895-8285896	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs142274562	chr8:8285898-8285899	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs61015795	chr8:8285900-8285901	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs369840131	chr8:8285901-8285902	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs374353254	chr8:8285904-8285905	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs533680363	chr8:8285914-8285915	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs76671075	chr8:8285918-8285919	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs545988225	chr8:8285939-8285940	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs576382986	chr8:8285982-8285983	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs551652460	chr8:8285984-8285985	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs539442807	chr8:8285985-8285986	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs556547285	chr8:8286002-8286003	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs375189715	chr8:8286043-8286044	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs576709700	chr8:8286070-8286071	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs74651525	chr8:8286106-8286107	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs2945858	chr8:8286116-8286117	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs183955263	chr8:8286125-8286126	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs114608374	chr8:8286154-8286155	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:137)

Disease	PMID	Source
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
Prostate cancer	16573809	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Autism	22495311	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16608533	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16774939	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Breast cancer	21990379	CNVD
Psoriasis	20403174	CNVD
Psoriasis	20663923	CNVD
Crohn''s disease	16909382	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Crohn''s disease	20877625	CNVD
Inflammatory disorder	20877625	CNVD
Cardiac defect	21933911	CNVD
Psoriasis	18059266	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Psoriasis	20877625	CNVD
Mental retardation	17847001	CNVD
Prostate cancer	17217626	CNVD
Schizophrenia	21399695	CNVD
Colorectal cancer	21128281	CNVD
Colorectal cancer	19455253	CNVD
Psoriasis	18848619	CNVD
Squamous cell cancer	19047905	CNVD
Colorectal cancer	17229543	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Bladder cancer	21909424	CNVD
Myxofibrosarcoma	16751306	CNVD
Immune disease	21572526	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Kallmann Syndrome 2	22470819	CNVD
Developmental disorder	20461109	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Glioblastoma multiforme	21138945	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:84 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:8273200-8289400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr8:8275400-8286000	Weak transcription	Gastric	stomach
3	chr8:8277200-8286600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
4	chr8:8277600-8285400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
5	chr8:8281800-8285600	Weak transcription	Rectal Mucosa Donor 31	rectum
6	chr8:8283800-8286200	Enhancers	Fetal Intestine Large	intestine
7	chr8:8284000-8287600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr8:8284200-8285400	Weak transcription	HSMMtube	muscle
9	chr8:8284200-8286200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr8:8284200-8287000	Enhancers	Fetal Kidney	kidney
11	chr8:8284600-8285800	Enhancers	Rectal Mucosa Donor 29	rectum
12	chr8:8284600-8287400	Enhancers	Stomach Mucosa	stomach
13	chr8:8284800-8285400	Enhancers	Pancreas	Pancrea
14	chr8:8284800-8285800	Enhancers	Cortex derived primary cultured neurospheres	brain
15	chr8:8284800-8285800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
16	chr8:8284800-8285800	Enhancers	Duodenum Mucosa	Duodenum
17	chr8:8284800-8286400	Enhancers	Fetal Intestine Small	intestine
18	chr8:8285000-8285400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
19	chr8:8285000-8285600	Enhancers	Brain Germinal Matrix	brain
20	chr8:8285000-8285800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr8:8285000-8285800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr8:8285000-8285800	Enhancers	HUES64 Cell Line	embryonic stem cell
23	chr8:8285000-8286000	Flanking Active TSS	HepG2	liver
24	chr8:8285000-8287200	Enhancers	Fetal Lung	lung
25	chr8:8285200-8285600	Flanking Active TSS	A549	lung
26	chr8:8285200-8285800	Enhancers	HUES6 Cell Line	embryonic stem cell
27	chr8:8285200-8285800	Enhancers	iPS-15b Cell Line	embryonic stem cell
28	chr8:8285400-8285600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
29	chr8:8285400-8285800	Enhancers	ES-I3 Cell Line	embryonic stem cell
30	chr8:8285400-8285800	Enhancers	Liver	Liver
31	chr8:8285400-8286000	Weak transcription	Pancreas	Pancrea
32	chr8:8285400-8286000	Enhancers	HSMMtube	muscle
33	chr8:8285400-8286200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr8:8285600-8286000	Enhancers	Rectal Mucosa Donor 31	rectum
35	chr8:8285600-8286600	Enhancers	A549	lung
36	chr8:8285800-8286600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
37	chr8:8285800-8286800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
38	chr8:8285800-8287000	Weak transcription	HUES6 Cell Line	embryonic stem cell
39	chr8:8285800-8287200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr8:8286000-8286200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
41	chr8:8286000-8286200	Enhancers	Gastric	stomach
42	chr8:8286000-8286200	Enhancers	Pancreas	Pancrea
43	chr8:8286000-8286400	Weak transcription	HSMMtube	muscle
44	chr8:8286000-8287400	Enhancers	NH-A	brain
45	chr8:8286000-8287600	Enhancers	HepG2	liver
46	chr8:8286200-8287200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr8:8286200-8287200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
48	chr8:8286200-8287400	Enhancers	Muscle Satellite Cultured Cells	--
49	chr8:8286200-8287400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
50	chr8:8286200-8287400	Enhancers	HSMM	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links